Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria.

Saved in:
Bibliographic Details
Title: Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria.
Authors: Summitt CB; Center for Structural Biology and Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC 27101, U.S.A., Johnson LC; Center for Structural Biology and Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC 27101, U.S.A., Jönsson TJ; Center for Structural Biology and Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC 27101, U.S.A., Parsonage D; Center for Structural Biology and Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC 27101, U.S.A., Holmes RP; †Department of Urology, University of Alabama at Birmingham, Birmingham, AL 35294, U.S.A., Lowther WT; Center for Structural Biology and Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC 27101, U.S.A.
Source: The Biochemical journal [Biochem J] 2015 Mar 01; Vol. 466 (2), pp. 273-81.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Published by Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 2984726R Publication Model: Print Cited Medium: Internet ISSN: 1470-8728 (Electronic) Linking ISSN: 02646021 NLM ISO Abbreviation: Biochem J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1470-8728
DOI:10.1042/BJ20141159